1. Home
  2. FENG vs GBIO Comparison

FENG vs GBIO Comparison

Compare FENG & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENG
  • GBIO
  • Stock Information
  • Founded
  • FENG 1998
  • GBIO 2016
  • Country
  • FENG China
  • GBIO United States
  • Employees
  • FENG N/A
  • GBIO N/A
  • Industry
  • FENG Broadcasting
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FENG Industrials
  • GBIO Health Care
  • Exchange
  • FENG Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • FENG 26.8M
  • GBIO 29.5M
  • IPO Year
  • FENG 2011
  • GBIO 2020
  • Fundamental
  • Price
  • FENG $2.11
  • GBIO $4.10
  • Analyst Decision
  • FENG
  • GBIO Strong Buy
  • Analyst Count
  • FENG 0
  • GBIO 4
  • Target Price
  • FENG N/A
  • GBIO $73.33
  • AVG Volume (30 Days)
  • FENG 3.6K
  • GBIO 207.7K
  • Earning Date
  • FENG 08-19-2025
  • GBIO 08-15-2025
  • Dividend Yield
  • FENG N/A
  • GBIO N/A
  • EPS Growth
  • FENG N/A
  • GBIO N/A
  • EPS
  • FENG N/A
  • GBIO N/A
  • Revenue
  • FENG $97,280,369.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • FENG N/A
  • GBIO N/A
  • Revenue Next Year
  • FENG N/A
  • GBIO N/A
  • P/E Ratio
  • FENG N/A
  • GBIO N/A
  • Revenue Growth
  • FENG 1.04
  • GBIO 146.47
  • 52 Week Low
  • FENG $1.28
  • GBIO $3.00
  • 52 Week High
  • FENG $3.60
  • GBIO $29.40
  • Technical
  • Relative Strength Index (RSI)
  • FENG 44.23
  • GBIO 47.69
  • Support Level
  • FENG $2.08
  • GBIO $4.11
  • Resistance Level
  • FENG $2.23
  • GBIO $4.83
  • Average True Range (ATR)
  • FENG 0.09
  • GBIO 0.45
  • MACD
  • FENG -0.01
  • GBIO -0.06
  • Stochastic Oscillator
  • FENG 12.90
  • GBIO 18.03

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: